Atlanta Center for Medical Research (ACMR), a national leader in clinical research solutions, announced Eric Riesenberg will begin serving as CEO, effective immediately. Riesenberg has been an advisor to ACMR’s board of directors since 2001, and he became director of operations in 2008. He succeeds his father, ACMR founder, Dr. Robert Riesenberg, as CEO.
“ACMR has seen great growth throughout the past decade,” said Riesenberg, “and I’m grateful for the opportunity to grow with it.”
In 2008, Riesenberg joined ACMR full time in an effort to help reinvigorate the business. As Director of Operations, Riesenberg tapped his background in accounting and business to help guide ACMR through notable staff and facility expansions.
This included spearheading ACMR’s 2014 move from Midtown to its current location in Southwest Atlanta. ACMR now offers 150,000 square feet of space purposefully designed and dedicated to conducting research studies from small Biotech to large pharmaceutical companies. The Center, which continues to be the crown jewel of Atlanta’s medical research industry, offers 200 inpatient beds in 15 separate unit spaces and the latest medical research equipment.
“Our professional staff never fails to impress with their dedication and contributions to medicine and the community,” said Riesenberg. “And I couldn’t be prouder of our amazing facility and the groundbreaking research taking place within. I’m thrilled at the prospect of ACMR’s future.”
Riesenberg currently serves on the board of advisors to the Metro Atlanta Chamber of Commerce and works with the Bioscience Leadership Council. He is a member of the American Israel Chamber of Commerce and works with the medical committee. He also serves on the board of several small businesses to advise on growth and challenges. He is a member of the Drug Information Association (DIA) and American Society of Clinical Psychopharmacology (ASCP) . He is a Licensed CPA and is a Chartered Global Management Accountant.